| 2D Structure | |
| CID | 13810 |
| IUPAC Name | 2-hydroxypropane-1,2,3-tricarboxylic acid;N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| InChI | InChI=1S/C22H28N2O.C6H8O7/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,21H,2,13-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) |
| InChI Key | IVLVTNPOHDFFCJ-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C28H36N2O8 |
| Molecular Weight | 528.6 |
| synonyms | ['FENTANYL CITRATE', '990-73-8', 'Leptanal', 'Oralet', 'Phentanyl citrate', 'Actiq', 'Abstral', 'Lazanda', 'Onsolis', 'Instanyl', 'Fentanyl buccal', 'McN-JR-4263-49', 'Fentanyl citrate cii', 'SUBLIMAZE PRESERVATIVE FREE', 'MUN5LYG46H', 'N-(1-Phenethyl-4-piperidyl)propionanilide citrate', 'FENTANYL CITRATE PRESERVATIVE FREE', 'Kw-2246', 'N-(1-Phenethyl-4-piperidyl)propionanilide dihydrogen citrate', 'N-(1-Phenethyl-4-piperidinyl)propionanilide dihydrogen citrate', 'Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)', 'CHEBI:31602', 'DTXSID80243933', 'Fentyl', 'Fentanyl Nasal Spray', 'RefChem:57750', 'Transmucosal Fentanyl Citrate', 'DTXCID10166424', 'N-(1-Phenethylpiperidin-4-yl)-N-phenylpropanamide monocitrate', 'Fentanyl dihydrogen citrate', 'Fentanyl citrate salt', 'Fentanyl.citrate', 'N-(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1)', 'Fentaz', 'N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide citrate', 'Fentanyl Citrate (1mg/ml in Methanol)', 'McN-JR 4263', 'EINECS 213-588-0', 'UNII-MUN5LYG46H', 'R 5240', 'fentanyl monocitrate', 'Abstral (TN)', 'Fentora (TN)', 'Lazanda (TN)', 'Oralet (TN)', 'Fentanyl citrate [USAN:USP:BAN:JAN]', 'Propionanilide, N-(1-phenethyl-4-piperidyl)-, citrate (1:1)', 'CHEMBL688', 'SCHEMBL40733', 'R-4263 CITRATE', 'FENTANYL CITRATE [MI]', 'FENTANYL CITRATE [JAN]', 'Fentanyl citrate (JP18/USP)', 'FENTANYL CITRATE [USAN]', 'FENTANYL CITRATE [VANDF]', 'Fentanyl citrate CRS - * narc', 'FENTANYL CITRATE [MART.]', 'FENTANYL CITRATE [WHO-DD]', 'FENTANYL CITRATE [EMA EPAR]', 'N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide citrate salt', 'FENTANYL CITRATE [GREEN BOOK]', 'AKOS024457504', 'FENTANYL CITRATE [ORANGE BOOK]', 'FENTANYL CITRATE CII [USP-RS]', 'FENTANYL CITRATE [EP MONOGRAPH]', 'FENTANYL CITRATE [USP MONOGRAPH]', 'Fentanyl Citrate (1 mg/ml in Methanol)', 'INNOVAR COMPONENT FENTANYL CITRATE', '2-hydroxypropane-1,2,3-tricarboxylic acid;N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide', 'NS00076423', 'D01399', 'Fentanyl.citrate, 1mg/ml in Methanol (as free base)', 'Q27104201', 'N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide citrate', 'Fentanyl citrate, European Pharmacopoeia (EP) Reference Standard', 'Fentanyl citrate, United States Pharmacopeia (USP) Reference Standard', '2-Hydroxypropane-1,2,3-tricarboxylic acid--N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (1/1)', 'N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide 2-hydroxypropane-1,2,3-tricarboxylate'] |
From Pubchem